The global biomaterials market size is expected to reach USD 348.4 billion by 2027, registering a CAGR of 15.9% over the forecast period, according to a new report by Grand View Research, Inc. The application of biomaterials represents a fast-growing field in biomedical research. Recent advances in the improvement of bioactivity, compatibility, and mechanical properties of biomaterials have introduced new opportunities for their application in tissue engineering, immune engineering, and drug delivery systems.
Biocompatibility, low toxicity,
and renewable nature of polymeric biomaterials make them potent drug delivery
agents in controlled and targeted drug delivery, thus providing lucrative
opportunities for the market growth. The advent of improved drug delivery
approaches, such as PEG-coated liposomes, biopolymer-coated liposomes, and
nanomaterials drug delivery, further expands the prospects of these biopolymers
in the pharmaceutical and medical industries.
Use of biomaterials has greatly
benefited the regeneration of the cardiopulmonary system. These materials
provide physical support and physiological and chemical cues to seeded cells to
assist the tissue regeneration process. Integration of biomaterials with
nanotechnology techniques also stimulates the regeneration of damaged
cardiomyocyte’s extracellular matrix, thus replacing the traditional organ
transplantation procedures.
For Full Research Report On Biomaterials Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/biomaterials-industry
Biomaterials Market
Report Highlights
- High availability of natural
and synthetic degradable polymers and their wide usage as surgical sutures
and implants resulted in the largest revenue share of the polymers product
segment
- Natural products have gained
immense popularity as a source of novel bioactive substance for the
development of novel drugs, leading to fastest growth of this segment
- Increasing incidence of
chronic skeletal and musculoskeletal conditions is expected to raise the
demand for biomaterials for orthopedics application at a large scale
- Improvement in the surface
modification of silicone breast implants to prevent capsular contracture
is one of the factors driving the biomaterial usage in the plastic surgery
segment at the fastest rate
- North America is expected to
dominate the biomaterials market in terms of revenue share owing to the
presence of public and private agencies promoting biomaterial usage by
hosting events and funding initiatives
- Asia Pacific is anticipated
to grow at a rapid pace owing to the presence of several local
manufacturers developing low-cost biomaterial products, mainly in China
- Prominent players operating
in the market include Medtronic, Evonik, DSM, BASF, Berkeley Advanced
Biomaterials, Covalon Technologies, and Zimmer Biomet Holdings
- Companies are engaged in
several strategic growth initiatives, such as novel product developments,
partnerships, and regional expansion to reinforce their market presence
- For instance, in November
2019, Evonik partnered with BellaSeno GmbH for development and
commercialization of 3D printed breast implant by using Evonik’s RESOMER
bioresorbable polymer.
Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/biomaterials-industry/request/rs1
Biomaterials Market
Segmentation
Grand View Research has segmented
the global biomaterials market on the basis of product, application, and
region:
Biomaterials
Product Outlook (Revenue, USD Million, 2016 - 2027)
- Metallic
- Natural
- Ceramics
- Polymers
Biomaterials Application
Outlook (Revenue, USD Million, 2016 - 2027)
- Cardiovascular
- Sensors
- Stents
- Guidewires
- Implantable Cardiac
Defibrillators
- Pacemakers
- Vascular Grafts
- Others
- Ophthalmology
- Synthetic Corneas
- Intraocular Lens
- Contact Lens
- Ocular Tissue Replacement
- Others
- Dental
- Tissue Regeneration
Materials
- Dental Implants
- Bone Grafts &
Substitutes
- Dental Membranes
- Others
- Orthopedic
- Joint Replacement
biomaterials
- Orthobiologics
- Bioresorbable Tissue
Fixation Products
- Viscosupplementation
- Spine Biomaterial
- Others
- Wound Healing
- Fracture Healing Device
- Adhesion Barrier
- Skin Substitutes
- Internal Tissue Sealant
- Surgical Hemostats
- Others
- Tissue Engineering
- Plastic Surgery
- Facial Wrinkle Treatment
- Soft Tissue Fillers
- Craniofacial Surgery
- Bioengineered Skins
- Peripheral Nerve Repair
- Acellular Dermal Matrices
- Others
- Neurology
- Neural Stem Cell
Encapsulation
- Shunting Systems
- Hydrogel Scaffold For CNS
Repair
- Cortical Neural Prosthetics
- Others
- Others
Biomaterials
Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- Middle East and Africa (MEA)
- South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based
market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment